140 related articles for article (PubMed ID: 6965951)
21. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
[TBL] [Abstract][Full Text] [Related]
22. Maturation-linked expression of C3b and C3b' receptors on developing human bone marrow and peripheral blood granulocytes.
Scott CS
Clin Exp Immunol; 1981 Apr; 44(1):201-10. PubMed ID: 7261476
[TBL] [Abstract][Full Text] [Related]
23. C3 contributes to the cross-protective immunity induced by Babesia gibsoni phosphoriboprotein P0 against a lethal B. rodhaini infection.
Terkawi MA; Zhang G; Jia H; Aboge G; Goo YK; Nishikawa Y; Yokoyama N; Igarashi I; Kawazu SI; Fujisaki K; Xuan X
Parasite Immunol; 2008; 30(6-7):365-70. PubMed ID: 18533933
[TBL] [Abstract][Full Text] [Related]
24. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
Sim E; Sim RB
Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
[TBL] [Abstract][Full Text] [Related]
25. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
Schmitt M; Mussel HH; Dierich MP
J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
[TBL] [Abstract][Full Text] [Related]
26. Binding of soluble 125I-human C3b, the third component of complement, to specific receptors in human cultured B lymphoblastoids cells: characterization of a low affinity interaction.
Frade R; Strominger J
J Immunol; 1980 Sep; 125(3):1332-9. PubMed ID: 6967899
[No Abstract] [Full Text] [Related]
27. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
Krettli AU; Pontes de Carvalho LC
Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
[TBL] [Abstract][Full Text] [Related]
28. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
Alper CA; Abramson N; Johnston RB; Jandl JH; Rosen FS
J Clin Invest; 1970 Nov; 49(11):1975-85. PubMed ID: 4097977
[TBL] [Abstract][Full Text] [Related]
29. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
[TBL] [Abstract][Full Text] [Related]
30. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
Arend WP; Massoni RJ
Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
[TBL] [Abstract][Full Text] [Related]
31. Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.
Ziegler JB; Alper CA; Rosen RS; Lachmann PJ; Sherington L
J Clin Invest; 1975 Mar; 55(3):668-72. PubMed ID: 1117072
[TBL] [Abstract][Full Text] [Related]
32. Erythrocyte-bound complement components in health and disease.
Garratty G
Prog Clin Biol Res; 1980; 43():133-55. PubMed ID: 6999500
[No Abstract] [Full Text] [Related]
33. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
34. [Activity of the red-cell C3b receptor and the circulating immuno-complex in patients of herpes simplex keratitis].
He YL
Zhonghua Yan Ke Za Zhi; 1989 Sep; 25(5):286-8. PubMed ID: 2534477
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
37. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.
Newman SL; Johnston RB
J Immunol; 1979 Oct; 123(4):1839-46. PubMed ID: 573303
[No Abstract] [Full Text] [Related]
38. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
Melamed J; Arnaout MA; Colten HR
J Immunol; 1982 May; 128(5):2313-8. PubMed ID: 6801135
[TBL] [Abstract][Full Text] [Related]
39. C3 cleaved by membrane proteases binds to C3b acceptors expressed on concanavalin A-stimulated human lymphocytes and enhances antibody-dependent cellular cytotoxicity.
Erdei A; Benczur M; Fábry Z; Dierich MP; Gergely J
Scand J Immunol; 1984 Aug; 20(2):125-31. PubMed ID: 6236547
[TBL] [Abstract][Full Text] [Related]
40. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
Marquart HV; Svehag SE; Leslie RG
J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
